Impact Biomedical Inc (IBO)

$0.47 -0.03 (-5.40%)
Market Cap 5.69M
Revenue (ttm) 0.00
Net Income (ttm) -24.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 248,100
Avg Vol 8,174,328
Day's Range N/A - N/A
Shares Out 12.09M
Stochastic %K 17%
Beta N/A
Analysts Strong Buy
Price Target N/A

Latest News on IBO

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Mar 21, 2025, 2:38 PM EDT - 2 months ago

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Impact BioMedical Inc. to Present at The Microcap Conference

Jan 23, 2025, 4:30 PM EST - 4 months ago

Impact BioMedical Inc. to Present at The Microcap Conference

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

Oct 15, 2024, 6:00 AM EDT - 8 months ago

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

Oct 7, 2024, 8:30 AM EDT - 8 months ago

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

Sep 26, 2024, 8:30 AM EDT - 9 months ago

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

Sep 17, 2024, 11:29 AM EDT - 9 months ago

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

Impact BioMedical Inc. Announces Pricing of Initial Public Offering

Sep 16, 2024, 10:24 AM EDT - 9 months ago

Impact BioMedical Inc. Announces Pricing of Initial Public Offering

Impact BioMedical IPO Registration Document (S-1)

Nov 21, 2023, 11:48 AM EST - 1 year ago

Impact BioMedical IPO Registration Document (S-1)